Details for New Drug Application (NDA): 063321
✉ Email this page to a colleague
NDA 063321 describes VANCOLED, which is a drug marketed by Lederle and Hikma and is included in two NDAs. Additional details are available on the VANCOLED profile page.
The generic ingredient in VANCOLED is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOLED is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 063321
| Tradename: | VANCOLED |
| Applicant: | Lederle |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063321
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Oct 15, 1993 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 500MG BASE/6ML | ||||
| Approval Date: | Oct 15, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
